PCH
Polar Capital Holdings Portfolio holdings
AUM
$21.9B
1-Year Est. Return
83.22%
This Fund
S&P 500
1 Year Est. Return
+83.22%
AUM
$20.7B
AUM Growth
+$1.68B
(+8.8%)
Holding
309
Top Buys
| 1 | +$155M | |
| 2 | +$153M | |
| 3 | +$151M | |
| 4 |
TTM Technologies
TTMI
|
+$142M |
| 5 |
Carvana
CVNA
|
+$132M |
Top Sells
| 1 | +$215M | |
| 2 | +$212M | |
| 3 | +$192M | |
| 4 |
Vertiv
VRT
|
+$184M |
| 5 |
CYBR
CyberArk
CYBR
|
+$172M |
Sector Composition
| 1 | Technology | 48.46% |
| 2 | Financials | 15.84% |
| 3 | Healthcare | 14.87% |
| 4 | Communication Services | 10.81% |
| 5 | Consumer Discretionary | 5.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RAPP
126
Rapport Therapeutics
RAPP
$1.35B
| $27.9M | 0.13% |
+938,952
|
|
||
127
Tencent Music
TME
$22.2B
| $27.8M | 0.13% |
+1,190,843
|
|
||
128
Jones Lang LaSalle
JLL
$14.8B
| $27.7M | 0.13% |
92,753
+51,243
|
|
||
129
Thermo Fisher Scientific
TMO
$191B
| $27.6M | 0.13% |
+56,824
|
|
||
130
BBB Foods
TBBB
$4.09B
| $26.6M | 0.13% |
985,507
-30,527
|
|
||
131
Exact Sciences
EXAS
$19.7B
| $25.6M | 0.12% |
467,134
+160,202
|
|
||
132
JFrog
FROG
$4.97B
| $25.1M | 0.12% |
529,836
+311,410
|
|
||
133
Edwards Lifesciences
EW
$50.6B
| $24.7M | 0.12% |
317,886
+63,208
|
|
||
134
Steris
STE
$24.3B
| $24.6M | 0.12% |
+99,504
|
|
||
135
Analog Devices
ADI
$172B
| $24.1M | 0.12% |
97,947
-2,705
|
|
||
136
Cenovus Energy
CVE
$43B
| $23.1M | 0.11% |
1,094,259
+44,966
|
|
||
137
Penumbra
PEN
$13.4B
| $23M | 0.11% |
90,877
+24,504
|
|
||
138
McKesson
MCK
$121B
| $22.8M | 0.11% |
29,476
-113
|
|
||
139
Globant
GLOB
$2.14B
| $22.5M | 0.11% |
391,977
-10,249
|
|
||
140
Kymera Therapeutics
KYMR
$7.21B
| $22.5M | 0.11% |
397,041
+147,041
|
|
||
141
Qualcomm
QCOM
$150B
| $22.4M | 0.11% |
134,402
+4,138
|
|
||
142
Revolution Medicines
RVMD
$19.6B
| $22.3M | 0.11% |
478,105
-273,550
|
|
||
143
Mastercard
MA
$465B
| $22.2M | 0.11% |
38,944
-15,738
|
|
||
144
Fidelity National Information Services
FIS
$25.9B
| $21.9M | 0.11% |
332,258
-36,391
|
|
||
145
Marvell Technology
MRVL
$68.5B
| $21.9M | 0.11% |
260,000
+27,000
|
|
||
146
Apogee Therapeutics
APGE
$4.85B
| $20.8M | 0.1% |
524,094
+29,094
|
|
||
147
DexCom
DXCM
$28.4B
| $20.8M | 0.1% |
+308,478
|
|
||
148
Xometry
XMTR
$2.15B
| $20.4M | 0.1% |
374,991
-57,796
|
|
||
|
ORKA
149
Oruka Therapeutics
ORKA
$1.63B
| $19.9M | 0.1% |
1,032,307
+57,307
|
|
||
150
Bank of America
BAC
$359B
| $19.8M | 0.1% |
384,376
-41,595
|
|